Natalie Eddington

Natalie D. Eddington, PhD, FAAPS, FCP, is dean of the University of Maryland School of Pharmacy (UMSOP) and a professor of pharmaceutical sciences. She is also executive director of University Regional Partnerships for the University of Maryland, Baltimore (UMB).

Dr. Eddington is a nationally known expert in drug delivery and pharmacokinetics. Her research focuses on various medications used in the treatment of cancer, epilepsy, arthritis, and drugs of abuse and on understanding the role of biopharmaceutics and pharmacokinetics in elucidating the underlying mechanisms important in optimizing drug therapy. 

Under Dr. Eddington’s leadership, the School of Pharmacy has established a number of centers and programs including the FDA-supported Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI), which is a collaborative agreement with the FDA to promote innovation in support of the development and evaluation of safe and effective products. Dr. Eddington has designed numerous international regulatory courses for clinicians and scientists from South Korea, Argentina, Brazil, the United States, and Japan on the United States’ drug development process and the FDA regulatory infrastructure surrounding medication and device development. Most recently, under Dr. Eddington’s leadership, the School has launched a transformational pharmapreneurism initiative, which seeks to position the School’s world class faculty, its wonderful students, and exceptional staff to achieve their career aspirations and address our nation’s health care, research, policy, and societal needs.